Financhill
Sell
30

DQ Quote, Financials, Valuation and Earnings

Last price:
$17.49
Seasonality move :
20.74%
Day range:
$17.15 - $17.80
52-week range:
$13.62 - $30.85
Dividend yield:
0%
P/E ratio:
10.38x
P/S ratio:
0.90x
P/B ratio:
0.24x
Volume:
614.7K
Avg. volume:
885.3K
1-year change:
-24.75%
Market cap:
$1.2B
Revenue:
$2.3B
EPS (TTM):
-$1.85
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $350M $675.6M $1.7B $4.6B $2.3B
Revenue Growth (YoY) 16.05% 93.03% 148.49% 174.5% -49.92%
 
Cost of Revenues $269.9M $441.6M $581.6M $1.2B $1.4B
Gross Profit $80.1M $234M $1.1B $3.4B $920.7M
Gross Profit Margin 22.89% 34.64% 65.36% 73.95% 39.9%
 
R&D Expenses $5.7M $6.9M $6.5M $10M $10.1M
Selling, General & Admin $32.5M $39.5M $39.9M $354.1M $213.2M
Other Inc / (Exp) -$186K -- $4M $1.8M -$17.3M
Operating Expenses $32.6M $46.1M $45.8M $367.3M $137.2M
Operating Income $47.5M $187.9M $1.1B $3B $783.4M
 
Net Interest Expenses $9.4M $25.7M $20.5M -- --
EBT. Incl. Unusual Items $37.9M $162.1M $1B $3.1B $818.5M
Earnings of Discontinued Ops. $1.3M -$141K -- -- --
Income Tax Expense $9.6M $28.2M $170.1M $577.2M $165.6M
Net Income to Company -- $133.9M $864.8M $2.5B $652.9M
 
Minority Interest in Earnings $1K -$4.6M -$115.9M -$659.8M -$223.3M
Net Income to Common Excl Extra Items $29.5M $129.2M $748.9M $1.8B $429.5M
 
Basic EPS (Cont. Ops) $0.45 $1.80 $10.15 $24.00 $5.75
Diluted EPS (Cont. Ops) $0.40 $1.70 $9.75 $23.35 $5.75
Weighted Average Basic Share $67.9M $71M $73.9M $75.9M $74.7M
Weighted Average Diluted Share $70M $75M $76.8M $77.3M $75M
 
EBITDA $47.3M $256.5M $1.1B $3.1B $932.3M
EBIT $47.3M $187.9M $1.1B $3B $783.4M
 
Revenue (Reported) $350M $675.6M $1.7B $4.6B $2.3B
Operating Income (Reported) $47.5M $187.9M $1.1B $3B $783.4M
Operating Income (Adjusted) $47.3M $187.9M $1.1B $3B $783.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $125.5M $585.8M $1.2B $484.8M $198.5M
Revenue Growth (YoY) 49.6% 366.65% 108.22% -60.25% -59.06%
 
Cost of Revenues $80.3M $150.6M $241.1M $417M $259.1M
Gross Profit $45.3M $435.2M $978.6M $67.8M -$60.6M
Gross Profit Margin 36.05% 74.29% 80.24% 13.99% -30.53%
 
R&D Expenses $1.7M $1.9M $2.5M $2.8M $813K
Selling, General & Admin $9.2M $11.4M $280.2M $89.7M $37.7M
Other Inc / (Exp) -- $695K $393K $3M $7.5M
Operating Expenses $11.9M $13.5M $285.6M $45.3M $37.4M
Operating Income $33.3M $421.7M $693M $22.5M -$98M
 
Net Interest Expenses $5.2M $4.5M -- -- --
EBT. Incl. Unusual Items $28.1M $417.9M $701M $39.3M -$88.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $6.2M $62.1M $155.2M $21.4M -$12M
Net Income to Company $21.9M $355.8M $545.8M $17.8M -$76.9M
 
Minority Interest in Earnings -$1.1M -$63.4M -$222.4M -$24.2M $16.2M
Net Income to Common Excl Extra Items $20.8M $292.3M $323.4M -$6.3M -$60.7M
 
Basic EPS (Cont. Ops) $0.29 $3.95 $4.28 -$0.09 -$0.92
Diluted EPS (Cont. Ops) $0.27 $3.81 $4.18 -$0.09 -$0.92
Weighted Average Basic Share $71.3M $74M $75.6M $74M $66.3M
Weighted Average Diluted Share $76.6M $76.7M $76.7M $74.2M $66.3M
 
EBITDA $33.5M $421.7M $693M $22.5M -$98M
EBIT $33.5M $421.7M $693M $22.5M -$98M
 
Revenue (Reported) $125.5M $585.8M $1.2B $484.8M $198.5M
Operating Income (Reported) $33.3M $421.7M $693M $22.5M -$98M
Operating Income (Adjusted) $33.5M $421.7M $693M $22.5M -$98M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $546.8M $1.5B $4.1B $2.7B $1.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $387.2M $564.1M $1.2B $1.2B $1.4B
Gross Profit $159.6M $966.9M $3B $1.5B -$60.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $7M $6.7M $8.6M $9.6M $7.4M
Selling, General & Admin $36.8M $40.9M $320.3M $218.2M $152.7M
Other Inc / (Exp) $4K $695K $5.2M -$16.8M $12.4M
Operating Expenses $39.7M $45.6M $333.2M $179.1M $119.4M
Operating Income $120M $921.3M $2.6B $1.3B -$179.9M
 
Net Interest Expenses $21.4M $26.5M -- -- --
EBT. Incl. Unusual Items $98.6M $895.5M $2.7B $1.4B -$131.1M
Earnings of Discontinued Ops. -$447K -- -- -- --
Income Tax Expense $20.5M $133.3M $479M $295.9M -$2.6M
Net Income to Company $49.6M $762.1M $2.2B $1.1B -$128.5M
 
Minority Interest in Earnings -$1.1M -$81.7M -$544M -$352.1M $16.8M
Net Income to Common Excl Extra Items $76.5M $680.5M $1.6B $708.9M -$111.7M
 
Basic EPS (Cont. Ops) $1.09 $9.24 $21.71 $9.60 -$1.85
Diluted EPS (Cont. Ops) $1.02 $8.88 $21.19 $9.48 -$1.85
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $120.9M $921.5M $2.6B $1.3B -$179.9M
EBIT $120.9M $921.5M $2.6B $1.3B -$179.9M
 
Revenue (Reported) $546.8M $1.5B $4.1B $2.7B $1.3B
Operating Income (Reported) $120M $921.3M $2.6B $1.3B -$179.9M
Operating Income (Adjusted) $120.9M $921.5M $2.6B $1.3B -$179.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $427.9M $1.3B $3.7B $1.8B $833.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $303.4M $425.9M $1B $997.9M $981.4M
Gross Profit $124.5M $857.4M $2.7B $833.5M -$147.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $5.4M $5.2M $7.3M $6.9M $4.2M
Selling, General & Admin $28.2M $29.7M $310.1M $174.2M $113.7M
Other Inc / (Exp) -- $695K $1.9M -$16.7M $13M
Operating Expenses $34.6M $34.1M $321.5M $133.3M $115.5M
Operating Income $89.9M $823.3M $2.4B $700.1M -$263.2M
 
Net Interest Expenses $17.7M $18.5M $5.1M -- --
EBT. Incl. Unusual Items $72.2M $805.5M $2.4B $722M -$227.6M
Earnings of Discontinued Ops. -$141K -- -- -- --
Income Tax Expense $14.6M $119.7M $428.6M $147.2M -$20.9M
Net Income to Company $57.6M $685.8M $2B $574.7M -$206.6M
 
Minority Interest in Earnings -$1.1M -$78.2M -$506.3M -$198.5M $41.6M
Net Income to Common Excl Extra Items $56.4M $607.6M $1.5B $376.2M -$165M
 
Basic EPS (Cont. Ops) $0.80 $8.23 $19.81 $4.82 -$2.49
Diluted EPS (Cont. Ops) $0.74 $7.92 $19.35 $4.77 -$2.49
Weighted Average Basic Share $211.8M $221.1M $225.4M $229.1M $198M
Weighted Average Diluted Share $229.2M $230.1M $230M $230M $198M
 
EBITDA $90.6M $823.3M $2.4B $700.1M -$263.2M
EBIT $90.6M $823.3M $2.4B $700.1M -$263.2M
 
Revenue (Reported) $427.9M $1.3B $3.7B $1.8B $833.7M
Operating Income (Reported) $89.9M $823.3M $2.4B $700.1M -$263.2M
Operating Income (Adjusted) $90.6M $823.3M $2.4B $700.1M -$263.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $51.8M $76.6M $723.8M $3.5B $3B
Short Term Investments -- -- $280.3M $13.9M --
Accounts Receivable, Net $13K -- -- -- --
Inventory $39.3M $49.2M $327.8M $169.5M $173.3M
Prepaid Expenses $13.1M $9.6M $3.4M $852K $14.3M
Other Current Assets $905K $2.8M $41.7M $52.9M $224.6M
Total Current Assets $174.3M $180.3M $1.7B $4.9B $3.6B
 
Property Plant And Equipment $995.2M $1B $1.6B $2.6B $3.6B
Long-Term Investments $642K -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $29.6M $30.8M $40.7M $80.3M $150.4M
Other Long-Term Assets $217K $957K $820K $735K $28.3M
Total Assets $1.2B $1.2B $3.3B $7.6B $7.4B
 
Accounts Payable $12.7M $19M $81.5M $81.9M $92.9M
Accrued Expenses $8M $11.3M $40.8M $51.5M $73.1M
Current Portion Of Long-Term Debt $128.6M $70.4M -- -- --
Current Portion Of Capital Lease Obligations $85K $82K -- -- --
Other Current Liabilities $5M $4.4M -- -- --
Total Current Liabilities $445.1M $284.1M $550.5M $736.5M $836.4M
 
Long-Term Debt $151.5M $123.2M -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $634.2M $440.2M $679.8M $989.5M $978.6M
 
Common Stock $35K $37K $38K $40K $41K
Other Common Equity Adj -$19.9M $26.3M $67.8M -$176M -$294M
Common Equity $566.6M $767.1M $2.2B $4.8B $4.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $515K $31.8M $501.9M $1.8B $1.7B
Total Equity $567.2M $798.9M $2.7B $6.6B $6.4B
 
Total Liabilities and Equity $1.2B $1.2B $3.3B $7.6B $7.4B
Cash and Short Terms $51.8M $76.6M $1B $3.5B $3B
Total Debt $381.3M $243M -- $20.7M --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $70.2M $660.9M $3.1B $3.3B $853.4M
Short Term Investments -- $414.2M $31.7M $2.7M $1.5B
Accounts Receivable, Net $42K $72K -- -- $84.5M
Inventory $53.6M $46.2M $73.3M $129.1M $206.9M
Prepaid Expenses $1.2M $26.7M -- -- --
Other Current Assets $13M $7.3M $12.8M $150.6M $292.6M
Total Current Assets $179.8M $1.5B $4.7B $3.8B $2.9B
 
Property Plant And Equipment $987.4M $1.4B $2B $3.2B $3.9B
Long-Term Investments $658K $693K -- -- $28.5M
Goodwill -- -- -- -- --
Other Intangibles $29.8M $36.9M $77.6M $147.8M $159.9M
Other Long-Term Assets $147K $93K $47.9M $71M $59.3M
Total Assets $1.2B $3B $6.9B $7.3B $7B
 
Accounts Payable $19.7M $22.2M $107.7M $100.5M $40.9M
Accrued Expenses $16.6M $47M -- -- --
Current Portion Of Long-Term Debt $131.1M -- -- -- --
Current Portion Of Capital Lease Obligations $78K -- -- -- --
Other Current Liabilities -- -- $287M $165.1M $77.6M
Total Current Liabilities $335.5M $428.8M $909.8M $810.3M $629.1M
 
Long-Term Debt $140M -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $514.4M $543.5M $1B $948.1M $724.3M
 
Common Stock $36K $37K -- -- --
Other Common Equity Adj -$2.6M $39.7M -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $26.1M $456.1M $1.6B $1.6B $1.6B
Total Equity $684.8M $2.4B $5.9B $6.3B $6.3B
 
Total Liabilities and Equity $1.2B $3B $6.9B $7.3B $7B
Cash and Short Terms $70.2M $1.1B $3.1B $3.3B $2.3B
Total Debt $333.2M -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- $133.9M $864.8M $2.5B $652.9M
Depreciation & Amoritzation -- $68.7M $77.4M $107.1M $148.9M
Stock-Based Compensation -- $17.9M $10.1M $307.4M $141.9M
Change in Accounts Receivable -- $5.5M -$360.1M -$816.2M $987.4M
Change in Inventories -- -$5.1M -$280.2M $138.3M -$13.1M
Cash From Operations -$933K $209.7M $639M $2.5B $1.6B
 
Capital Expenditures -- $118.3M $508.3M $1.3B $1.2B
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$118.5M -$781.9M -$998.4M -$1.2B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $121.4M $62M $178.8M $140M
Long-Term Debt Repaid -- -$245.6M -$262.9M -$178.8M -$140M
Repurchase of Common Stock -- -- -- -$124.9M -$522.1M
Other Financing Activities -- $28.1M $935M $1.6B -$303.7M
Cash From Financing $791K -$95.5M $736.2M $1.5B -$795.4M
 
Beginning Cash (CF) $1.5M $115.3M $118.4M $724M $3.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$142K -$4.3M $593.3M $2.9B -$375.3M
Ending Cash (CF) $1.3M $118.4M $724M $3.5B $3B
 
Levered Free Cash Flow -$933K $91.4M $130.7M $1.2B $429.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $21.9M $355.8M $545.8M $17.8M -$76.9M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $24.2M $210.8M $568.2M $711.1M -$97.8M
 
Capital Expenditures $80.1M -- -- $458.4M $33.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$20M -$600.3M -$525M -$458.6M -$65.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$15.2M -- -- -- --
Cash From Financing -$15.2M $778.7M -$101.4M -$124.5M -$5.5M
 
Beginning Cash (CF) $116.4M $269.7M $3.3B $3.2B $997.5M
Foreign Exchange Rate Adjustment $4.3M $2M -$174.9M -$16.9M $25.2M
Additions / Reductions -$11M $389.2M -$58.2M $128M -$169.3M
Ending Cash (CF) $109.8M $660.9M $3.1B $3.3B $853.4M
 
Levered Free Cash Flow -$56M $210.8M $568.2M $252.7M -$131.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $49.6M $762.1M $2.2B $1.1B -$128.5M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$31.4M $791.7M $1.7B $2.3B -$257.9M
 
Capital Expenditures $80.1M $38.1M $508.3M $2.2B $557.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing $121.9M -$893.9M -$531.5M -$1.3B -$2B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$86.3M -- -- -- --
Cash From Financing -$74.7M $645.1M $1.5B -$607.8M -$241.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $15.8M $542.8M $2.6B $307.9M -$2.5B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$111.6M $753.5M $1.2B $47.4M -$815.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $57.6M $685.8M $2B $574.7M -$206.6M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $71.1M $653.1M $1.7B $1.5B -$376.5M
 
Capital Expenditures $80.1M -- -- $965.1M $335.6M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$80.3M -$855.8M -$605.4M -$954.3M -$1.7B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $1.1M -- -- -- --
Cash From Financing $1.1M $741.6M $1.5B -$602M -$48.5M
 
Beginning Cash (CF) $353.2M $616M $5.1B $10.8B $6.7B
Foreign Exchange Rate Adjustment $2.7M $3.6M -$242.4M -$180.7M -$21.8M
Additions / Reductions -$8.2M $538.9M $2.6B -$58.9M -$2.2B
Ending Cash (CF) $347.7M $1.2B $7.5B $10.6B $4.5B
 
Levered Free Cash Flow -$9M $653.1M $1.7B $532.3M -$712.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 1.47% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 10% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 1.24% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock